Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:CASNumber |
82571-53-7
|
| gptkbp:contains_functional_group |
gptkb:piperazine
gptkb:chlorobenzene ketone cyclohexyl group |
| gptkbp:has_not_been_marketed |
true
|
| gptkbp:hasMolecularFormula |
C21H31ClN2O
|
| gptkbp:hasUNII |
6Q1K1Q1K1F
|
| gptkbp:heldBy |
antipsychotic medication
dopamine receptor antagonist |
| https://www.w3.org/2000/01/rdf-schema#label |
OCL 481
|
| gptkbp:IUPACName |
1-(4-chlorophenyl)-4-(4-cyclohexylpiperazin-1-yl)butan-1-one
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL2106012
68728 |
| gptkbp:was_developed_as |
potential antipsychotic drug
|
| gptkbp:bfsParent |
gptkb:NGC_2169
gptkb:NGC_2186 |
| gptkbp:bfsLayer |
7
|